It also offers detailed and comprehensive coverage of industry revenue, volume, distribution and industry player share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in Netherlands

Scope of the Research

• The report provides neurology devices information broken down into detailed categories and sectors in Netherlands.
• Total revenues, products sold, end users, and average pricing.
• Industry shares of all the key competitors.
• Key pipeline products that are set to shape the industry , broken down by segment .
• Information on the top medical equipment industry players in the segment in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, Research and Development projects , corporate growths and contractions and regulation modifications .
• Key M&A deals , partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the neurology devices industry in Netherlands.
• Evaluate and compare the attractiveness of the industry in the country.
• Identify growth sectors and opportunities in each market segment within the country.
• Evaluate the pipeline of key products that will change the segment , and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the industry in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the industry in the country.
• Identify and analyze the strengths and weaknesses of the market incumbents in the country.

Table Of Contents

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of March kets Covered in the Report 14
3.1 Neurology Devices 14
3.2 CSF (Cerebro Spinal Fluid) Management 14
3.2.1 Hydrocephalus shunt 14
3.2.2 Intra Cranial Pressure (ICP) Monitors 14
3.3 Interventional Neurology 14
3.3.1 Aneurysm Clips 14
3.3.2 Embolic System 14
3.3.3 Navigational System 15
3.4 Neurostimulation Device 15
3.4.1 Spinal Cord Stimulator (SCS) 15
3.4.2 Deep Brain Stimulator (DBS) 15
3.4.3 Vagus Nerve stimulation (VNS) 15
3.5 Neurosurgical Products (Neuroendoscopes) 16
3.5.1 Neurosurgical Products (Neuroendoscopes) 16
3.6 Radio surgery 16
3.6.1 Cyber Knife Radiosurgery 16
3.6.2 Gamma Knife Radiosurgery 16
4 Healthcare Segment Review 17
4.1 Healthcare Expenditure 17
4.2 Healthcare Infrastructure 20
4.3 Healthcare Policy 22
4.3.1 Health Insurance Act 23
4.3.2 Healthcare Allowance Act 23
4.3.3 The Exceptional Medical Expenses Act 23
5 Regulation System 24
5.1 Medical Equipment Approval Process 24
5.1.1 Classification of Medical Devices 25
5.1.2 Conformity Assessment Process 34
5.2 Post March ket Surveillance (PMS) 37
6 Pricing and Reimbursement 38
6.1 Pricing and Reimbursement in Netherlands 38
7 Distribution Structure 39
7.1 Distribution Structure in Netherlands 39
8 Neurology Devices In Netherlands 40
8.1 Neurology Devices Cross Country Comparison (from 2000 to 2012 ) 40
8.2 Neurology Devices, Netherlands, Overall Revenues ($ mn), from 2000 to 2012 41
8.3 Neurology Devices, Netherlands, Category Volume (Units), from 2000 to 2012 45
8.4 Neurology Devices, Netherlands, Firms Share (2006-2007) 47
9 CSF Management In Netherlands 48
9.1 CSF Management Overall Revenue (from 2000 to 2012 ) 48
9.2 CSF Management Overall Volume (from 2000 to 2012 ) 50
9.3 CSF Management Average Price (from 2000 to 2012 ) 52
9.4 CSF Management Distribution Share (2006-2007) 53
9.5 CSF Management, Netherlands, Firms Share (2006-2007) 54
10 Interventional Neurology In Netherlands 55
10.1 Interventional Neurology Overall Revenue (from 2000 to 2012 ) 55
10.1.1 Embolic Systems Overall Revenues (from 2000 to 2012 ) 57
10.1.2 Navigational Systems Overall Revenues (from 2000 to 2012 ) 59
10.2 Interventional Neurology Overall Volume (from 2000 to 2012 ) 61
10.2.1 Embolic Systems Overall Volume (from 2000 to 2012 ) 63
10.2.2 Navigational Systems Overall Volume (from 2000 to 2012 ) 65
10.3 Interventional Neurology Average Price (from 2000 to 2012 ) 67
10.4 Interventional Neurology Distribution Share (2006-2007) 68
10.5 Interventional Neurology, Netherlands, Firms Share (2006-2007) 69
11 Neurostimulation Devices In Netherlands 70
11.1 Neurostimulation Devices Overall Revenue (from 2000 to 2012 ) 70
11.2 Neurostimulation Devices Overall Volume (from 2000 to 2012 ) 72
11.3 Neurostimulation Devices Average Price (from 2000 to 2012 ) 74
11.4 Neurostimulation Devices Distribution Share (2006-2007) 75
11.5 Neurostimulation Devices, Netherlands, Firms Share (2006-2007) 76
12 Neurosurgical Products (Neuroendoscopes) In Netherlands 77
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (from 2000 to 2012 ) 77
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (from 2000 to 2012 ) 79
12.3 Neurosurgical Products (Neuroendoscopes)Average Price (from 2000 to 2012 ) 81
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 82
12.5 Neurosurgical Products (Neuroendoscopes), Netherlands, Firms Share (2006-2007) 83
13 Radiosurgery In Netherlands 84
13.1 Radiosurgery Overall Revenue (from 2000 to 2012 ) 84
13.2 Radiosurgery Overall Volume (from 2000 to 2012 ) 86
13.3 Radiosurgery Average Price (from 2000 to 2012 ) 88
14 Medtronic, Inc. Firms Profile 89
14.1 Corporate Presentation 89
14.2 Value Chain Analysis 89
14.2.1 Manufacturing 90
14.2.2 Product Development 90
14.2.3 Sales and March keting 90
14.3 Medtronic, Inc. Pipeline Products 91
14.3.1 Medtronic, Inc. Pipeline Products by Equipment Type 91
14.3.2 Medtronic, Inc. Pipeline Products by Development Stage 93
14.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 95
14.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 97
14.3.5 Medtronic, Inc. Pipeline Products by News Summary 98
15 B. Braun Melsungen AG Firms Profile 99
15.1 Corporate Presentation 99
15.2 Value Chain Analysis 99
15.2.1 Manufacturing 100
15.2.2 Product Development 100
15.2.3 Sales and March keting 101
15.2.4 B. Braun Melsungen AG Pipeline Products by Equipment Type 102
15.2.5 B. Braun Melsungen AG Pipeline Products by Development Stage 102
15.2.6 B. Braun Melsungen AG Pipeline Products by Therapy Area 102
15.2.7 B. Braun Melsungen AG Pipeline Products by Clinical Trials 103
15.2.8 B. Braun Melsungen AG Pipeline Products by News Summary 103
16 Cyberonics, Inc. Firms Profile 104
16.1 Corporate Presentation 104
16.1.1 Cyberonics, Inc. Pipeline Products by Equipment Type 105
16.1.2 Cyberonics, Inc. Pipeline Products by Development Stage 105
16.1.3 Cyberonics, Inc. Pipeline Products by Therapy Area 105
17 Boston Scientific Corporation Firms Profile 106
17.1 Corporate Presentation 106
17.2 Value Chain Analysis 106
17.2.1 Manufacturing 107
17.2.2 Product Development 107
17.2.3 Sales and March keting 108
17.3 Boston Scientific Corporation Pipeline Products 109
17.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 109
17.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 110
17.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 111
17.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 112
17.3.5 Boston Scientific Corporation Pipeline Products by News Summary 113
18 Codman and Shurtleff, Inc. Firms Profile 115
18.1 Corporate Presentation 115
19 Advanced Neuromodulation Systems, Inc. Firms Profile 116
19.1 Corporate Presentation 116
20 Braintronics B.V. Firms Profile 117
20.1 Corporate Presentation 117
21 Medical Measurement Systems B.V. Firms Profile 118
21.1 Corporate Presentation 118
22 Mind Media B.V. Firms Profile 119
22.1 Corporate Presentation 119
23 Appendix 120
23.1 Global March kets Direct Research Methodology 120
23.2 Coverage 121
23.3 Secondary Research 121
23.4 Primary Research 122
23.5 Models 122
23.6 Projections 123
23.7 Expert Panels 123
23.8 Currency Conversion 124
23.9 Contact Us 125
23.10 Disclaimer 125



1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006 18
Figure 2: Healthcare Financing Framework in Netherlands, 2005 19
Figure 3: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007 26
Figure 4: Flowchart for Classification of Invasive Devices in Netherlands, 2007 27
Figure 5: Flowchart for Classification of Invasive Devices in Netherlands, 2007 28
Figure 6: Flowchart for Classification of Invasive Devices in Netherlands, 2007 29
Figure 7: Flowchart for Classification of Invasive Devices in Netherlands, 2007 30
Figure 8: Flowchart for Classification of Active Devices in Netherlands, 2007 31
Figure 9: Flowchart for Classification of Active Devices in Netherlands, 2007 32
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007 33
Figure 11: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007 34
Figure 12: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007 35
Figure 13: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007 36
Figure 14: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007 37
Figure 15: Neurology Devices Cross Country Comparison (from 2000 to 2012 ) 40
Figure 16: Neurology Devices, Netherlands, Overall Revenues ($ mn), from 2000 to 2012 41
Figure 17: Neurology Devices, Netherlands, Portfolio Analysis, from 2000 to 2012 42
Figure 18: Neurology Devices, Netherlands, Overall Revenues ($ mn), Historic, from 2000 to 2007 43
Figure 19: Neurology Devices, Netherlands, Firms Share (%), 2007 47
Figure 20: CSF Management, Netherlands, Revenue ($ mn), Historic, from 2000 to 2007 48
Figure 21: CSF Management, Netherlands, Revenue ($ mn), Projection , from 2007 to 2012 49
Figure 22: CSF Management, Netherlands, Overall Volume (Units), Historic, from 2000 to 2007 50
Figure 23: CSF Management, Netherlands, Overall Volume (Units), Projection , from 2007 to 2012 51
Figure 24: CSF Management, Netherlands, Firms Share (%), 2007 54
Figure 25: Interventional Neurology, Netherlands, Revenue ($ mn) by Segment, Historic, from 2000 to 2007 55
Figure 26: Interventional Neurology, Netherlands, Revenue ($ mn) by Segment, Projection , from 2007 to 2012 56
Figure 27: Embolic Systems, Netherlands, Revenues ($ mn) by Sub-Segment, Historic, from 2000 to 2007 57
Figure 28: Embolic Systems, Netherlands, Revenues ($ mn) by Sub-Segment, Projection , from 2007 to 2012 58
Figure 29: Navigational Systems, Netherlands, Revenues ($ mn) by Sub-Segment, Historic, from 2000 to 2007 59
Figure 30: Navigational Systems, Netherlands, Revenues ($ mn) by Sub-Segment, Projection , from 2007 to 2012 60
Figure 31: Interventional Neurology, Netherlands, Overall Volume (Units), Historic, from 2000 to 2007 61
Figure 32: Interventional Neurology, Netherlands, Overall Volume (Units), Projection , from 2007 to 2012 62
Figure 33: Embolic Systems, Netherlands, Volume (Units) by Sub-Segment, Historic, from 2000 to 2007 63
Figure 34: Embolic Systems, Netherlands, Volume (Units) by Sub-Segment, Projection , from 2007 to 2012 64
Figure 35: Navigational Systems, Netherlands, Volume (Units) by Sub-Segment, Historic, from 2000 to 2007 65
Figure 36: Navigational Systems, Netherlands, Volume (Units) by Sub-Segment, Projection , from 2007 to 2012 66
Figure 37: Interventional Neurology, Netherlands, Firms Share (%), 2007 69
Figure 38: Neurostimulation Devices, Netherlands, Revenue ($ mn), Historic, from 2000 to 2007 70
Figure 39: Neurostimulation Devices, Netherlands, Revenue ($ mn), Projection , from 2007 to 2012 71
Figure 40: Neurostimulation Devices, Netherlands, Overall Volume (Units), Historic, from 2000 to 2007 72
Figure 41: Neurostimulation Devices, Netherlands, Overall Volume (Units), Projection , from 2007 to 2012 73
Figure 42: Neurostimulation Devices, Netherlands, Firms Share (%), 2007 76
Figure 43: Neurosurgical Products (Neuroendoscopes), Netherlands, Revenue ($ mn), Historic, from 2000 to 2007 77
Figure 44: Neurosurgical Products (Neuroendoscopes), Netherlands, Revenue ($ mn), Projection , from 2007 to 2012 78
Figure 45: Neurosurgical Products (Neuroendoscopes), Netherlands, Overall Volume (Units), Historic, from 2000 to 2007 79
Figure 46: Neurosurgical Products (Neuroendoscopes), Netherlands, Overall Volume (Units), Projection , from 2007 to 2012 80
Figure 47: Neurosurgical Products (Neuroendoscopes), Netherlands, Firms Share (%), 2007 83
Figure 48: Radiosurgery, Netherlands, Revenue ($ mn), Historic, from 2000 to 2007 84
Figure 49: Radiosurgery, Netherlands, Revenue ($ mn), Projection , from 2007 to 2012 85
Figure 50: Radiosurgery, Netherlands, Overall Volume (Units), Historic, from 2000 to 2007 86
Figure 51: Radiosurgery, Netherlands, Overall Volume (Units), Projection , from 2007 to 2012 87
Figure 52: Medtronic, Inc. Value Chain Analysis 89
Figure 53: B. Braun Melsungen AG Value Chain Analysis 99
Figure 54: Boston Scientific Corporation Value Chain Analysis 106
Figure 55: Global March kets Direct Methodology 120

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.